← European Medicine Shortage Tracker · all medicines

Atosiban acetate shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Atosiban acetate currently has availability issues reported in 3 European registers: Spain, Ireland, Sweden.

Shortage  ATC — · also listed as: Atosiban · Atosiban acetate · atosibanacetat · data refreshed 28 October 2026

Key facts

As of 28 October 2026, 3 of the 10 tracked registers list current availability issues for Atosiban acetate, covering 4 affected product presentations. The longest-running open report was filed in Sweden on 2025-03-17 and has now been open for about 19 months. Where agencies state a cause, unexpectedly high demand lead with 1 of the 1 stated-cause reports. The furthest expected-resolution date currently on file is 2027-01-31; the earliest is 2026-10-31. Notably, 2 reports have already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. The issue spread across registers over time rather than at once: Sweden reported first (2025-03-17), with Ireland following roughly 18 months later — a pattern typical of supply problems cascading between national markets. Registers in Spain, Ireland, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇪🇸 SpainShortage
Atosiban SUN 6,75 mg/0,9 ml solucion inyectable EFG , 1 vial de 0,9 ml
2025-10-212027-01-31Existen otros medicamentos con el mismo principio activo y misma vía.
Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.
register ↗
🇮🇪 IrelandShortage
Tractocile 6.75 mg / 0.9 ml Solution for injection
2026-09-112026-10-31Unexpected increased demand (Ireland only)
Alternatives: Appropriate alternative medicine authorised
register ↗
🇸🇪 SwedenShortage
Atosiban SUN 37,5 mg/5 ml Koncentrat till infusionsvätska, lösning
+ 1 more products
Atosiban SUN 6,75 mg/0,9 ml Injektionsvätska, lösning
2025-03-172026-09-02—
Alternatives: Alternative(s) available — see the national register.
register ↗

New register reports per month

2025-03: 12025-04: 02025-05: 02025-06: 02025-07: 02025-08: 02025-09: 02025-10: 12025-11: 02025-12: 02026-01: 02026-02: 02026-03: 02026-04: 02026-05: 02026-06: 12026-07: 02026-08: 02026-09: 12025-032026-09

Full report history (4 register entries)

Every individual register entry for Atosiban acetate in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇮🇪 IETractocile 6.75 mg / 0.9 ml Solution for injectionShortage2026-09-112026-10-31Unexpected increased demand (Ireland only)
🇸🇪 SEAtosiban SUN 37,5 mg/5 ml Koncentrat till infusionsvätska, lösningShortage2026-06-092026-07-31
🇪🇸 ESAtosiban SUN 6,75 mg/0,9 ml solucion inyectable EFG , 1 vial de 0,9 mlShortage2025-10-212027-01-31Existen otros medicamentos con el mismo principio activo y m
🇸🇪 SEAtosiban SUN 6,75 mg/0,9 ml Injektionsvätska, lösningShortage2025-03-172026-09-02

Frequently asked

Is Atosiban acetate currently in shortage in Europe?

Yes. As of 28 October 2026, availability issues are reported in: Spain, Ireland, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Atosiban acetate shortage expected to end?

Agency prognoses on file range from 2026-10-31 to 2027-01-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Atosiban acetate?

4 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Atosiban acetate availability data come from?

Directly from the official medicines-agency registers that list Atosiban acetate: AEMPS CIMA (Spain), HPRA (Ireland), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Atosiban acetate — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/atosiban-acetate/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Atosiban acetate availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/atosiban-acetate/">Atosiban acetate shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Atosiban acetate: availability status across 3 European registers — European Medicine Shortage Tracker (MobiDoctor), 28 October 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.